Boston Scientific cuts full-year targets after cyberattack order disruption
Boston Scientific said it is unlikely to meet full-year sales growth and earnings expectations, citing a major cyberattack disclosed last month that left it unable to fill orders. Shares fell more than 4% Tuesday morning.